Autolus Therapeutics (AUTL) Income Statement (2022 - 2026)
Income Statement report data from Sep 30, 2022 to Mar 31, 2026 for Autolus Therapeutics (AUTL).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||
Total Revenue | 26M (+7.95%) | 24M (+14.63%) | 21M (+1.29%) | 21M (+132.96%) | 8.98M (+29833.33%) | 30K | - | - | 10M (+493.53%) | 1.70M | - | - | - | - |
Operating Expenses | ||||||||||||||
Research And Development | 21M (-40.47%) | 36M (+27.75%) | 28M (+1.68%) | 27M (+2.62%) | 27M (-13.30%) | 31M (-23.54%) | 40M (+10.13%) | 37M (+19.37%) | 31M (-18.30%) | 38M (+16.15%) | 32M (-2.74%) | 33M (+21.32%) | 27M (-27.21%) | 38M |
Selling General And Administrative | 40M (+11.62%) | 36M (-1.35%) | 36M (+19.85%) | 30M (+2.47%) | 30M (-13.90%) | 34M (+25.54%) | 27M (+24.79%) | 22M (+20.46%) | 18M (+15.58%) | 16M (+48.26%) | 11M (-4.59%) | 11M (+19.83%) | 9.28M (+12.76%) | 8.23M |
Operating Expenses | 61M (-14.38%) | 71M (+11.31%) | 64M (+11.21%) | 58M (+2.54%) | 56M (-13.62%) | 65M (-3.71%) | 68M (+15.60%) | 59M (+19.80%) | 49M (-8.30%) | 53M (+24.09%) | 43M (-3.20%) | 44M (+20.94%) | 37M (-20.04%) | 46M |
Depreciation And Amortization | 2.21M (+5.24%) | 2.10M (0.00%) | 2.10M (0.00%) | 2.10M (+5.53%) | 1.99M (+2.05%) | 1.95M (+2.63%) | 1.90M (0.00%) | 1.90M (+4.97%) | 1.81M (+2.26%) | 1.77M (+26.43%) | 1.40M (-6.67%) | 1.50M (-21.05%) | 1.90M (+5.56%) | 1.80M |
Operating Income | ||||||||||||||
Operating Income | -59.51M (-17.88%) | -72.47M (+1.19%) | -71.62M (+16.99%) | -61.22M (-6.16%) | -65.24M (-14.00%) | -75.86M (+11.76%) | -67.88M (+15.19%) | -58.93M (+52.04%) | -38.76M (-27.24%) | -53.27M (+24.17%) | -42.90M (-3.33%) | -44.38M (+13.36%) | -39.15M (-9.98%) | -43.49M |
Ebit | -59.51M (-17.88%) | -72.47M (+1.19%) | -71.62M (+16.99%) | -61.22M (-6.16%) | -65.24M (-14.00%) | -75.86M (+11.76%) | -67.88M (+15.19%) | -58.93M (+52.04%) | -38.76M (-27.24%) | -53.27M (+24.17%) | -42.90M (-3.33%) | -44.38M (+13.36%) | -39.15M (-9.98%) | -43.49M |
EBITDA | -57.30M (-18.56%) | -70.36M (+1.21%) | -69.52M (+17.59%) | -59.12M (-6.53%) | -63.25M (-14.43%) | -73.92M (+12.03%) | -65.98M (+15.69%) | -57.03M (+54.34%) | -36.95M (-28.25%) | -51.50M (+24.10%) | -41.50M (-3.22%) | -42.88M (+15.11%) | -37.25M (-10.65%) | -41.69M |
Other Income / Expenses | ||||||||||||||
Interest Income | 2.47M (-23.53%) | 3.23M (-26.26%) | 4.38M (-16.25%) | 5.23M (-14.82%) | 6.14M (-17.58%) | 7.45M (-10.46%) | 8.32M (-13.87%) | 9.66M (+39.39%) | 6.93M (+130.23%) | 3.01M (-17.53%) | 3.65M (+7.35%) | 3.40M (-1.45%) | 3.45M (+1929.41%) | 170K |
Interest Expense | 11M (-51.31%) | 23M (+117.11%) | 11M | -6.83M | 10M | -30.83M | 11M (+5.11%) | 10M (-47.22%) | 19M (-36.04%) | 30M (+501.40%) | 5.01M (-0.20%) | 5.02M (+2.24%) | 4.91M (+165.41%) | 1.85M |
Net Interest Income | -8.65M (-55.89%) | -19.61M (+219.38%) | -6.14M | 12M | -4.01M | 38M | -2.37M (+355.77%) | -520.00K (-95.79%) | -12.34M (-54.50%) | -27.12M (+1879.56%) | -1.37M (-15.43%) | -1.62M (+10.96%) | -1.46M (-13.10%) | -1.68M |
Other Non Operating Income | 100K (-80.77%) | 520K (+550.00%) | 80K (-42.86%) | 140K (+7.69%) | 130K (-40.91%) | 220K (+340.00%) | 50K (-16.67%) | 60K | -300.00K | 220K (+57.14%) | 140K (-70.83%) | 480K (-38.46%) | 780K | -3.74M |
Net Income | ||||||||||||||
Income Before Tax | -70.73M (-22.71%) | -91.51M (+16.44%) | -78.59M (+65.38%) | -47.52M (-30.06%) | -67.94M (+159.91%) | -26.14M (-68.15%) | -82.07M (+40.97%) | -58.22M (+10.47%) | -52.70M (-31.73%) | -77.19M (+68.28%) | -45.87M (+0.79%) | -45.51M (+14.26%) | -39.83M (-18.58%) | -48.92M |
Income Tax Expense | 860K | -1.18M | 530K (+32.50%) | 400K (-82.06%) | 2.23M (+52.74%) | 1.46M (+7200.00%) | 20K (-60.00%) | 50K | -10.00K (-50.00%) | -20.00K (0.00%) | -20.00K | 40K | -10.00K (-99.84%) | -6.15M |
Net Income From Continuing Operations | -71.60M (-20.74%) | -90.33M (+14.17%) | -79.12M (+65.11%) | -47.92M (-31.70%) | -70.16M (+154.11%) | -27.61M (-66.37%) | -82.09M (+40.88%) | -58.27M (+10.59%) | -52.69M (-31.72%) | -77.17M (+68.31%) | -45.85M (+0.66%) | -45.55M (+14.42%) | -39.81M (-6.92%) | -42.77M |
Net Income | -71.60M (-20.74%) | -90.33M (+14.17%) | -79.12M (+65.11%) | -47.92M (-31.70%) | -70.16M (+154.11%) | -27.61M (-66.37%) | -82.09M (+40.88%) | -58.27M (+10.59%) | -52.69M (-31.72%) | -77.17M (+68.31%) | -45.85M (+0.66%) | -45.55M (+14.42%) | -39.81M (-6.92%) | -42.77M |
Comprehensive Income Net Of Tax | -72.87M (-72.37%) | -263.71M (+210.61%) | -84.90M (+193.26%) | -28.95M (-51.01%) | -59.09M (-73.24%) | -220.84M (+300.94%) | -55.08M (-3.79%) | -57.25M (+8.78%) | -52.63M (-73.48%) | -198.48M (+283.98%) | -51.69M (+28.42%) | -40.25M (+17.79%) | -34.17M (-39.86%) | -56.82M |